HOME >> MEDICINE >> NEWS
New UCLA program to study the possible environmental causes of cancer

A new program at UCLA's Jonsson Cancer Center and the School of Public Health will seek to discover subtle variations in the human genetic blueprint that predispose some individuals to develop cancer after contact with environmental pollutants.

The program will explore, for example, why some individuals exposed to second-hand cigarette smoke develop lung cancer, while others do not. Bringing together the best environmental researchers and molecular biologists at UCLA, the program seeks to shed new light on how pollutants interact with genetics to cause a variety of cancers.

The $1 million effort is being funded with a leadership gift from Pacific Palisades resident Art Alper, who made the donation in memory of his wife, Ann Fitzpatrick Alper, who died last year from complications of lung cancer. The Ann Fitzpatrick Alper Program in Environmental Genomics will be headed by Dr. Robert H. Schiestl, UCLA professor of pathology, environmental health and radiation oncology.

"We'll investigate the molecular mechanism by which environmental agents such as air pollution, pesticides and radiation cause cancer and why a certain sub-population of people are more sensitive to these environmental exposures than the general population," Schiestl said. "With knowledge about the mechanism of this interaction between environmental exposure and genetic predisposition, it's our goal to develop improved biomarkers of exposure, to identify people at increased risk and to design nutritional and chemical interventions to counteract the development of cancer, especially in those with increased sensitivity."

The environmental genomics program will focus on six research projects that seek to:

  • Characterize genetically the effects of air pollution particles on the makeup of human cells.
  • Understand the relationship of environmental exposures and a nonsmoker's susceptibility to lung cancer.
  • Identify the specific protein that prevents a canc
    '"/>


Contact: Kim Irwin
kirwin@mednet.ucla.edu
310-206-2805
University of California - Los Angeles
28-Mar-2003


Page: 1 2 3

Related medicine news :

1. Opponents of needle-exchange programs should think about their message to drug users
2. TB Alliance announces new drug discovery program with GlaxoSmithKline
3. Hopkins convenes consensus conference to develop blueprint for nationwide matching program
4. School-based smoking prevention programs ineffective
5. Influenza vaccination programmes for children in USA and Canada based on little evidence
6. NYU Child Study Center receives grant from the American Red Cross September 11 recovery program
7. Researchers track programs success in curbing aggressive behavior
8. NHLBI study shows smoking cessation programs improve survival
9. Northwestern Memorial Hospital receives $10 million commitment to support preeminent heart program
10. Physicians call for increased funding for federal infectious disease programs
11. Clinical breast examination offers modest benefit to breast cancer screening program

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: New UCLA program study the possible environmental causes cancer

(Date:5/24/2013)... The leading retail brand Short Dresses ... prom dresses . Now that is quite unbelievable, especially in ... brand name since its origin. The retailer has already revealed ... this huge discount offer will be an added bonanza for ... privileged to announce that Short Dresses is to offer different ...
(Date:5/23/2013)... NY (PRWEB) May 24, 2013 Magnatag’s ... employee absentee patterns and reduces vacation conflicts. A Manufacturing ... problem with vacation conflicts; now employees and managers can ... have any problems. Attendance is important to us and ... are exposed. That may seem harsh but it has ...
(Date:5/23/2013)... May 24, 2013 Sublime Beauty® ... Cellulite Whisperer line, with a 35% discount ... Sale" includes two proprietary products, the Cellulite ... . , Purchasers receive a report "Getting Control ... Gel has a wonderful grapefruit scent," says Kathy ...
(Date:5/23/2013)... -- High blood glucose is associated with poor outcomes ... (IIT) to control hyperglycemia is a common practice in ... consistent benefit and even shows harms associated with the ... Physicians, (ACP) Clinical Guidelines Committee in a new evidence-based ... of Medical Quality . , "Clinicians caring for hospitalized ...
(Date:5/23/2013)... (PRWEB) May 23, 2013 Whether working ... Operations Forces and law enforcement need an added layer ... Security Enhancer, Night VISER , is an effective ... motion sensing system to increase border and perimeter security. ... VISER have more than tripled over the past three ...
Breaking Medicine News(10 mins):Health News:short prom dresses Offers Abnormally Low Discount on Its New Collections 2Health News:New Attendance, Vacation and Training Tracker Board Reduces Employee Conflicts and Improves Attendance 2Health News:Fresh Organics in the New Cellulite Whisperer® Products from Sublime Beauty®; "Get Ready for Summer Sale" Continues 2Health News:ACP issues recommendations for management of high blood glucose in hospitalized patients 2Health News:Lighting Up the Night: ARA Announces Record Sales of Its Night VISER System 2Health News:Lighting Up the Night: ARA Announces Record Sales of Its Night VISER System 3
(Date:5/23/2013)... 23, 2013  Spring Bank Pharmaceuticals, Inc., a biopharmaceutical ... infections, today announced that it has initiated dosing in ... once daily, oral therapy for the treatment of HCV ... and is designed to assess both the safety and ... first-in-class drug for the treatment of chronic HCV infections ...
(Date:5/23/2013)... FREDERICK, Md. , May 23, 2013  BioElectronics ... safe consumer medical devices, comments on the FDA panel ... Public Advisory Panel Reclassification – Pulsed Shortwave Therapy Meeting ... Gaithersburg, MD , USA.  The focus of the ... instructed the panel to focus solely on the application ...
(Date:5/23/2013)... , May 23, 2013 Halozyme Therapeutics, ... the appointment of David A. Ramsay ... was most recently Vice President, Corporate Development at ... "With his established financial management experience ... by working in our commercial group for the ...
Breaking Medicine Technology:Spring Bank Pharmaceuticals Initiates a Phase I Clinical Trial for SB 9200 in HCV-infected Patients 2Spring Bank Pharmaceuticals Initiates a Phase I Clinical Trial for SB 9200 in HCV-infected Patients 3BioElectronics and Pulsed Shortwave Therapy Make Progress 2Halozyme Therapeutics Names David A. Ramsay Chief Financial Officer 2
Cached News: